Abstract
Irrespective of cell type, stem cell therapy to prevent heart failure following myocardial infarction is beset by low donor cell retention. Cell loss may be prevented by immobilisation within a...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
